Company · CIK 0001770121
Sana Biotechnology, Inc.
SANASearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$2.37+$0.03 (+1.28%)
SANA · Last trade
- Prev close
- $2.34
- Range (30d)
- $2.27 – $2.79
On the record
Recent filings
- 8-KSANACurrent report0001193125-26-384405 · 3.6 MBSEC(opens sec.gov)
- SCHEDULE 13G/ASANASana Biotechnology, Inc.0001012975-26-000773 · 30.7 KBSEC(opens sec.gov)
- 10-QSANAQuarterly update0001193125-26-342395 · 12.1 MBSEC(opens sec.gov)
- 8-KSANACurrent report0001193125-26-342371 · 541.2 KBSEC(opens sec.gov)
- 8-KSANACurrent report0001193125-26-259532 · 183.1 KBSEC(opens sec.gov)
- 10-QSANAQuarterly update0001193125-26-216769 · 10.6 MBSEC(opens sec.gov)
- 8-KSANACurrent report0001193125-26-216758 · 431.2 KBSEC(opens sec.gov)
- 8-KSANACurrent report0001193125-26-174531 · 190.1 KBSEC(opens sec.gov)
- 8-KSANACurrent report0001193125-26-152868 · 561.8 KBSEC(opens sec.gov)
- 10-KSANAAnnual report0001193125-26-088215 · 50.0 MBSEC(opens sec.gov)
Insiders
- AFEYAN NOUBAR10% Owner
- AGARWAL SUNILEVP, Head of Development & CMO
- ARCH Venture Fund IX, L.P.10% Owner
- ARCH Venture Fund X, L.P.10% Owner
- ARCH Venture Partners IX, LLC10% Owner
- ARCH Venture Partners IX, L.P.10% Owner
- ARCH Venture Partners X, LLC10% Owner
- Bilenker Joshua H.Director
- Bishop Hans EdgarDirector
- Burow Kristina10% Owner
Tickers
Addresses
business
188 EAST BLAINE STREET, SUITE 350
SEATTLE, WA
mailing
188 EAST BLAINE STREET, SUITE 350
SEATTLE, WA
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies